27 C
Lucknow
April 14, 2024
The Hona News
health

Atezolizumab addition to chemotherapy after surgery does not improve survival for triple negative breast cancer: Study



Patients with triple-negative breast cancer do not benefit from the addition of atezolizumab to their post-surgery chemotherapy treatment, according to the results of a large phase 3 clinical trial presented at the 14th European Breast Cancer Conference.



Source link

Related posts

Quitting smoking at any age brings big health benefits, fast: Study

asdavi92

Study explores accuracy of computerized ADHD test

asdavi92

Incisionless device could revolutionize treatment for diabetes, liver disease and severe obesity

asdavi92

Leave a Comment